SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Sol-Gel Technologies Ltd. (SLGL) (CIK 0001684693) (SLGL) — Apr 4, 2019

Sol-Gel Technologies Ltd. (SLGL) (CIK 0001684693)
Date: April 4, 2019 · CIK: 0001684693 · Accession: 0000000000-19-006500

AI Filing Summary & Sentiment

File numbers found in text: 333-230564

Date
April 2, 2019
Author
Not clearly detected
Form
UPLOAD
Company
Sol-Gel Technologies Ltd. (SLGL) (CIK 0001684693)

Letter

April 2, 2019 Gilad Mamlok Chief Financial Officer Sol-Gel Technologies Ltd. 7 Golda Meir Street Weizmann Science Park Ness Ziona, 7403650, Israel Re:Sol-Gel Technologies Ltd. Registration Statement on Form F-3 Filed March 28, 2019 File No. 333-230564 Dear Mr. Mamlok: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Nathan Ajiashvili, Esq.

Show Raw Text
April 2, 2019
Gilad Mamlok
Chief Financial Officer
Sol-Gel Technologies Ltd.
7 Golda Meir Street
Weizmann Science Park
Ness Ziona, 7403650, Israel
Re:Sol-Gel Technologies Ltd.
Registration Statement on Form F-3
Filed March 28, 2019
File No. 333-230564
Dear Mr. Mamlok:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tonya K. Aldave at (202) 551-3601 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Nathan Ajiashvili, Esq.